76 related articles for article (PubMed ID: 7540229)
21. Platelet activation in patients with obstructive sleep apnea syndrome and effects of nasal-continuous positive airway pressure.
Shimizu M; Kamio K; Haida M; Ono Y; Miyachi H; Yamamoto M; Shinohara Y; Ando Y
Tokai J Exp Clin Med; 2002 Dec; 27(4):107-12. PubMed ID: 12713015
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of desflurane and sevoflurane on the expression of platelet surface glycoproteins in unstimulated and adenosine diphosphate-induced platelets in vitro.
Koroglu A; Cicek M; Toprak HI; Karakoc Y; Noyan F; Ersoy OM
J Clin Anesth; 2007 Aug; 19(5):328-33. PubMed ID: 17869981
[TBL] [Abstract][Full Text] [Related]
23. ThromboFix platelet stabilizer: advances in clinical platelet analyses by flow cytometry?
Schmidt V; Hilberg T
Platelets; 2006 Jun; 17(4):266-73. PubMed ID: 16769604
[TBL] [Abstract][Full Text] [Related]
24. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
25. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Purdy G; Lawrie AS; Watt H; Brown MM; Machin SJ
Br J Haematol; 2004 Jun; 125(6):777-87. PubMed ID: 15180868
[TBL] [Abstract][Full Text] [Related]
26. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood.
Macey M; McCarthy D; Azam U; Milne T; Golledge P; Newland A
Cytometry B Clin Cytom; 2003 Jan; 51(1):30-40. PubMed ID: 12500295
[TBL] [Abstract][Full Text] [Related]
27. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM
Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485
[TBL] [Abstract][Full Text] [Related]
28. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation.
Vidal C; Spaulding C; Picard F; Schaison F; Melle J; Weber S; Fontenay-Roupie M
Thromb Haemost; 2001 Sep; 86(3):784-90. PubMed ID: 11583308
[TBL] [Abstract][Full Text] [Related]
30. Does renal carcinoma affect the expression of P-selectin on platelets?
Mantur M; Kemona H; Pietruczuk M; Wasiluk A
Neoplasma; 2002; 49(4):243-5. PubMed ID: 12382022
[TBL] [Abstract][Full Text] [Related]
31. The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation Group.
Becker RC; Tracy RP; Bovill EG; Mann KG; Ault K
Coron Artery Dis; 1994 Apr; 5(4):339-45. PubMed ID: 7519107
[TBL] [Abstract][Full Text] [Related]
32. Comparison of platelet activation in platelet concentrates measured by flow cytometry or ADVIA 2120.
Beard MJ; Jeewa Z; Bashir S; Cardigan R; Thomas S
Vox Sang; 2011 Aug; 101(2):122-30. PubMed ID: 21492182
[TBL] [Abstract][Full Text] [Related]
33. Amyloid beta-protein precursor-rich platelet microparticles in thrombotic disease.
Nomura S; Komiyama Y; Miyake T; Miyazaki Y; Kido H; Suzuki M; Kagawa H; Yanabu M; Takahashi H; Fukuhara S
Thromb Haemost; 1994 Oct; 72(4):519-22. PubMed ID: 7533336
[TBL] [Abstract][Full Text] [Related]
34. [Modified flow cytometry assay for CD62p expression of preserved platelets].
Ouyang XL; Liu JH; Shi Q; Gao DY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):462-5. PubMed ID: 12513750
[TBL] [Abstract][Full Text] [Related]
35. [Detection of platelet activation by flow cytometry in patients with pre-eclampsia].
Yi ZS; Zhou SY; Meng FY; Feng R; Liu QF; Lin R
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1095-6. PubMed ID: 14559705
[TBL] [Abstract][Full Text] [Related]
36. [The preparation and evaluation of the quality control materials for detection of platelet membrane glycoproteins by flow cytometry].
Liu YQ; Gong Y; Qu CX; You R; Li LP; Xing LS; Wang JZ
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(14):1096-1101. PubMed ID: 28395437
[No Abstract] [Full Text] [Related]
37. Removal by white cell-reduction filters of activated platelets expressing CD62.
Pedigo M; Wun T; Paglieroni T
Transfusion; 1993; 33(11):930-5. PubMed ID: 7505067
[TBL] [Abstract][Full Text] [Related]
38. [The clinical significance of platelet activation during exercise-induced myocardial ischemia].
Pan YZ; Wu BM; Hong XS
Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):106-8. PubMed ID: 7520851
[TBL] [Abstract][Full Text] [Related]
39. Can the risk for acute cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker P-selectin?
Itoh T; Nakai K; Ono M; Hiramori K
Coron Artery Dis; 1995 Aug; 6(8):645-50. PubMed ID: 8574460
[TBL] [Abstract][Full Text] [Related]
40. Large platelets continue to circulate in an activated state after myocardial infarction.
Schultheiss HP; Tschoepe D; Esser J; Schwippert B; Roesen P; Nieuwenhuis HK; Schmidt-Soltau C; Strauer B
Eur J Clin Invest; 1994 Apr; 24(4):243-7. PubMed ID: 7519556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
